About Medivolve Inc.[edit]
Medivolve Inc. (NEO: MEDV, OTC: MEDVF) is a healthcare technology and services company headquartered in Toronto, Canada. The company was incorporated in 2005 and was formerly known as QuestCap Inc.[1] It is a social-impact investment-focused firm that invests Bandwith, funds, and resources in improving human conditions via medical sciences, climate change, and technology.
The company provides a telehealth platform, a clinical diagnostic network, and a data-driven artificial intelligence (AI) framework to improve patient care. Medivolve offers a network of retail collection sites, which provides clinical services in diagnostic testing, vaccinations, and other point-of-care services.[2]
Mergers and Acquisitions[edit]
Marbella[edit]
On August 16, 2021, the company announced the acquisition of Marbella, an open-door retail pharmacy. Marbella is located in San Juan Capistrano, California. The pharmacy specializes in immunizations, traditional medication and non-sterile compounded products, and specialty and maintenance medications. The pharmacy became CalVax approved and participated in the California COVID-19 Vaccination initiative, administering vaccines through its retail locations, as earlier announced in June 2021.[3]
Myosin EHR Application[edit]
On May 2021, Medivolve announced that “the company has signed the definitive agreement and closed the transaction to acquire a 100% interest in the Electronic Health Record application and all associated intellectual property and technology (the “App”) from Myosin.”[4]
Business Plans and Accomplishments[edit]
Medivolve’s main objective is to reinvent the healthcare system leveraging a bespoke telehealth platform, a clinical diagnostic network, and a data-driven AI framework to improve patient care. “On the B2B side, we’ll be able to supply healthcare networks and medical partners with the tools to streamline services all underpinned by our Electronic Health Record platform. By partnering with clinical diagnostic labs and pharmacies, we will create a full-circle health management solution that constantly draws from our technology to deliver smarter, automated clinical decisions.”[5]
Through the acquisition of Myson, the electronic health record platform, Medivolve has managed to improve patient care and achieved better collaboration with clinicians via the efficient cloud-based system. The personalized patient portals streamline patient intake forms and medical reports, saving on the time required to submit orders, access reports, and share results.[5]
The company was actively involved in providing solutions for the Nobel pandemic through research, COVID-19 testing, immunity scoring, and vaccinations. On August 24, 2021, Medivolve rolled out its first two mobile COVID-19 testing vans servicing Las Vegas, Nevada, and surrounding areas. The testing opportunities were expanded to schools, workplaces, and events. Medivolve's mobile testing vans were outfitted with the appropriate testing equipment, supplies, and technology to secure patient registration.[6]
- ↑ Yahoo Finance. MEDVF Stock Profile. Retrieved on 1/1/2024.
- ↑ CNBC. MEDVF Quote. Retrieved on 1/1/2024.
- ↑ PR Newswire. Health Tech Company Medivolve Finalizes Acquisition of CalVax Licensed Marbella Pharmacy. August 16, 2021.
- ↑ Yahoo Finance. Medivolve Closes Acquisition of Industry-Leading Electronic Health Platform as Next Step in Transforming Human Health Management Across the United States. May 28, 2021.
- ↑ 5.0 5.1 medivolve.ca. Home. Retrieved on 1/1/2024.
- ↑ PR Newswire. Medivolve Announces New COVID-19 Testing Mobile Vans Expanding On-Site Testing Opportunities to Schools, Workplaces, and Events. August 24, 2021.
